Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 20, 2020

SELL
$6.69 - $13.45 $5,117 - $10,289
-765 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$14.59 - $23.84 $11,161 - $18,237
765 New
765 $11,000
Q4 2018

Jan 24, 2019

SELL
$14.59 - $23.84 $11,161 - $18,237
-765 Closed
0 $0
Q2 2018

Jul 24, 2018

SELL
$16.77 - $24.71 $2,599 - $3,830
-155 Reduced 16.85%
765 $19,000
Q1 2018

Apr 12, 2018

SELL
$16.68 - $22.07 $1,868 - $2,471
-112 Reduced 10.85%
920 $16,000
Q4 2017

Jan 12, 2018

SELL
$11.23 - $19.1 $6,794 - $11,555
-605 Reduced 36.96%
1,032 $20,000
Q3 2017

Oct 10, 2017

BUY
$15.41 - $32.17 $25,226 - $52,662
1,637
1,637 $29,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track First Command Financial Services, Inc. Portfolio

Follow First Command Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Financial Services, Inc. with notifications on news.